Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(2'-hydroxypropan-2'-yl)-5-methylcyclohexanol
2. 2-hydroxy-alpha,alpha,4-trimethylcyclohexanemethanol
3. Geranodyle
4. P-menthane-1,8-diol
5. P-menthane-3,8-diol
6. Para-menthane-3,8-diol
7. Terpin
8. Terpin, Monohydrate(cis)-isomer
9. Terpin, Titanium (+4) Salt
1. 2451-01-6
2. Terpin Monohydrate
3. Terpin (hydrate)
4. P-menthane-1,8-diol Monohydrate
5. Terpin Cis-form Hydrate
6. Cis-terpin Hydrate
7. Terpinol Hydrate
8. Terpinene Hydrate
9. 4-(2-hydroxypropan-2-yl)-1-methylcyclohexanol Hydrate
10. Cyclohexanemethanol, 4-hydroxy-alpha,alpha,4-trimethyl-, Monohydrate
11. Cis-p-methane-1,8-diol Monohydrate
12. Terpinol
13. Cis-p-menthane-1,8-diol Monohydrate
14. Terpin Monohydrate;cis-terpin Hydrate
15. Nsc-760418
16. S3v868548t
17. Terpin Hydrate (usp)
18. Terpin Hydrate [usp]
19. Terpine Hydrate
20. Terpinhydrate
21. Ai3-01762
22. Schembl29867
23. Terpin Hydrate [vandf]
24. Schembl2487459
25. Terpin Hydrate [mart.]
26. Chembl2105614
27. Terpin Hydrate [usp-rs]
28. Terpin Hydrate [who-dd]
29. Unii-s3v868548t
30. 4-(2-hydroxypropan-2-yl)-1-methylcyclohexan-1-ol Hydrate
31. 4-(2-hydroxypropan-2-yl)-1-methylcyclohexan-1-ol,hydrate
32. Dtxsid00947401
33. Hms3264b12
34. P-menthane-1,8-diol, Monohydrate
35. Hy-b1063
36. Mfcd00167312
37. S4577
38. Terpin Cis-form Hydrate [mi]
39. Akos016013500
40. Akos024288517
41. Terpin Hydrate [usp Monograph]
42. Ccg-213672
43. Ccg-266507
44. Cs-4619
45. Db13163
46. Ks-1430
47. Nsc 760418
48. Terpin Monohydrate [ep Monograph]
49. D06081
50. D92597
51. Sr-01000944230
52. J-015549
53. Q2273017
54. Sr-01000944230-1
55. 4-(2-hydroxypropan-2-yl)-1-methyl-cyclohexan-1-ol
56. 4-(2-hydroxypropan-2-yl)-1-methylcyclohexan-1-ol;hydrate
57. 4-(2-hydroxypropan-2-yl)-1-methylcyclohexan-1-ol--water (1/1)
58. Rel-(1s,4s)-4-(2-hydroxypropan-2-yl)-1-methylcyclohexanol Hydrate
59. Terpin Hydrate, United States Pharmacopeia (usp) Reference Standard
60. Cis-4-hydroxy-alpha,alpha,4-trimethylcyclohexanemethanol Monohydrate
61. Cyclohexanemethanol, 4-hydroxy-.alpha.,.alpha.,4-trimethyl-, Hydrate (1:1), Cis-
62. Cyclohexanemethanol, 4-hydroxy-.alpha.,.alpha.,4-trimethyl-, Monohydrate
63. Cyclohexanemethanol, 4-hydroxy-alpha,alpha,4-trimethyl-, Hydrate (1:1), Cis-
Molecular Weight | 190.28 g/mol |
---|---|
Molecular Formula | C10H22O3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 190.15689456 g/mol |
Monoisotopic Mass | 190.15689456 g/mol |
Topological Polar Surface Area | 41.5 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 155 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Terpin hydrate is used in the treatment of acute and chronic bronchitis, pneumonia, bronchiectasis, chronic obstructive pulmonary disease, infectious and inflammatory diseases of the upper respiratory tract.
It acts to facilitate the removal of mucus from the respiratory tract. It prevents the exacerbation of excessive mucus production and secretion due to airway bacterial or viral infections, asthma or chronic bronchitis. Expectorants like terpin hydrate change mucus consistency and make coughing more productive.
Expectorants
Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)
Terpin hydrate improves mucociliary function by working directly on the bronchial secretory cells in the lower respiratory tract to liquify and facilitate the elimination of bronchial secretionsas well as exerting a weak antiseptic effect on the pulmonary parenchyma. It is thought to increase the amount of fluid in the respiratory tract, which increases the flow and clearance of local irritants and as well as reducing the viscosity of mucus.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4701
Submission : 1982-11-01
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?